Author

Todd Hembrough

Institution: NantOmics LLC (United States)

Observed institution: NantOmics LLC (United States)

ORCID: 0009-0005-9250-2175

Observed ORCID: 0009-0005-9250-2175

OpenAlex ID: A5140517827

Data from Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR-Altered Solid Tumors

2026 · Cinta Hierro, Mònica Sánchez-Guixé, et al.

Supplementary Data 1 from Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR-Altered Solid Tumors

2026 · Cinta Hierro, Mònica Sánchez-Guixé, et al.

Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR -Altered Solid Tumors

2026 · Cinta Hierro, Mònica Sánchez-Guixé, et al. · Clinical Cancer Research

Works count: 3

Citation count:

H-index:

I10-index: